This year’s ‘Hot Topics’ will ignite your practice
Take note of what’s new now!
S004 – Hot Topics
9 a.m.-noon | Friday, March 8
Room 20B
This year’s S004 – Hot Topics will again stay true to delivering the newest and most relevant research, treatments, and techniques to the practice of dermatology. Topics cover cosmeceuticals, alopecia, biologics and psoriasis, atopic dermatitis, melanoma, acne, and dermatological surgery.
The Friday symposium will feature industry leaders with expertise in clinical practice, new medical and surgical approaches, and other dermatological insights that represent a true reflection of AAD member concerns and interests, according to session director Kenneth Tomecki, MD, FAAD, vice chair of the department of dermatology at Cleveland Clinic in Ohio.
Inquiring minds drive topics
“The information presented in Hot Topics was established by registrant consensus and will be directly applicable to patient care, if not immediately, then in the near future,” said Dr. Tomecki.
Not so absurd
The cosmeceutical market — cosmetic products that contain ingredients with biological properties which allegedly provide medical benefits — is booming, with new products coming to market daily. In “Cosmeceuticals: Naturally Absurd,” Cheri Frey, MD, FAAD, assistant professor of dermatology at Howard University in Washington, D.C., will discuss new and trending skincare ingredients, the science behind these cosmeceutical products, and what dermatologists need to know to advise their patents.
“Because our patients are also consumers, it’s important that we lead the discussions around skincare and make evidenced-based recommendations to our patients,” Dr. Frey said.
Getting the life they deserve
It’s an exciting time in the atopic dermatitis field now, with many developments in the systemic and the topical arena. In “Atopic Dermatitis: New Developments,” Emma Guttman, MD, PhD, FAAD, a professor of dermatology at the Icahn School of Medicine at Mount Sinai in New York City, will discuss drugs for atopic dermatitis that are expected to be approved soon, such as lebrikizumab, for moderate to severe atopic dermatitis, and those in the approval pipeline.
“Atopic dermatitis is at the forefront of innovation, with many biologics, small molecule drugs, and oral medications coming into the field. Novel topicals are also starting to get approval,” Dr. Guttman said. “It’s an exciting time to be a dermatologist because our patients with atopic dermatitis can now live completely normal lives and forget they have the disease.”
And there’s more!
The session line-up also features Andrea L. Zaenglein, MD, FAAD, a dermatology professor at Penn State College of Medicine in Hershey. Dr. Zaenglein will discuss what’s new in acne care. Natasha Mesinkovska, MD, PhD, FAAD, associate professor of dermatology at the University of California, Irvine School of Medicine, will present “Hairy Matters: What’s New in Alopecia.” Allan C. Halpern, MD, FAAD, chief of the dermatology service at Memorial Sloan Kettering Cancer Center in New York City, will provide an update on melanoma treatments.
Joseph Merola, MD, MSc, FAAD, chair of dermatology at University of Texas Southwestern Medical School in Dallas, will explore “Biologics and Psoriasis: The Beat Goes on,” and Anthony V. Benedetto, DO, FAAD, founder and medical director of the Dermatologic SurgiCenter in Philadelphia and Drexel Hill, Pennsylvania, will close the session with a discussion on the latest developments in dermatological surgery.
